- Report
- March 2025
Global
From €1999EUR$2,095USD£1,675GBP
€3808EUR$3,990USD£3,191GBP
- Report
- March 2025
Europe
From €3808EUR$3,990USD£3,191GBP
- Report
- March 2025
United States
From €1999EUR$2,095USD£1,675GBP
€3808EUR$3,990USD£3,191GBP
- Report
- March 2025
Middle East
From €1999EUR$2,095USD£1,675GBP
€3808EUR$3,990USD£3,191GBP
- Report
- March 2025
Asia Pacific
From €1999EUR$2,095USD£1,675GBP
€3808EUR$3,990USD£3,191GBP
- Report
- November 2024
- 799 Pages
Global
From €4580EUR$4,799USD£3,837GBP
- Report
- October 2024
- 186 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 188 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 181 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 186 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- June 2024
- 210 Pages
Global
From €2186EUR$2,290USD£1,831GBP
- Report
- January 2025
- 163 Pages
Global
From €2854EUR$2,990USD£2,391GBP
- Report
- September 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- March 2025
- 182 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 400 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- March 2025
- 175 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- August 2024
- 137 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- September 2024
- 145 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- April 2024
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP

The Biological Products for Human Use market is a subset of the biopharmaceutical industry, which focuses on the development and production of drugs and other treatments derived from living organisms. These products are used to treat a variety of medical conditions, ranging from cancer to autoimmune diseases. Biological products are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create new proteins or other molecules.
The Biological Products for Human Use market is highly regulated, with stringent safety and efficacy standards in place to ensure the safety of patients. Companies in this market must adhere to Good Manufacturing Practices (GMP) and other regulatory requirements in order to obtain approval from regulatory authorities.
Some of the major companies in the Biological Products for Human Use market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more